HEADER HYDROLASE 07-JAN-19 6QEB TITLE ASSESSMENT OF A LARGE ENZYME-DRUG COMPLEX BY PROTON-DETECTED SOLID- TITLE 2 STATE NMR WITHOUT DEUTERATION COMPND MOL_ID: 1; COMPND 2 MOLECULE: CARBONIC ANHYDRASE 2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CARBONATE DEHYDRATASE II,CARBONIC ANHYDRASE C,CAC,CARBONIC COMPND 5 ANHYDRASE II,CA-II; COMPND 6 EC: 4.2.1.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CA2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI K-12; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 83333 KEYWDS HCAII SOLID STATE NMR ACETAZOLAMIDE, HYDROLASE EXPDTA SOLID-STATE NMR NUMMDL 20 AUTHOR S.K.VASA REVDAT 5 14-JUN-23 6QEB 1 REMARK REVDAT 4 21-AUG-19 6QEB 1 REMARK REVDAT 3 17-APR-19 6QEB 1 JRNL REVDAT 2 13-MAR-19 6QEB 1 JRNL REVDAT 1 06-FEB-19 6QEB 0 JRNL AUTH S.K.VASA,H.SINGH,K.GROHE,R.LINSER JRNL TITL ASSESSMENT OF A LARGE ENZYME-DRUG COMPLEX BY PROTON-DETECTED JRNL TITL 2 SOLID-STATE NMR SPECTROSCOPY WITHOUT DEUTERATION. JRNL REF ANGEW.CHEM.INT.ED.ENGL. V. 58 5758 2019 JRNL REFN ESSN 1521-3773 JRNL PMID 30688395 JRNL DOI 10.1002/ANIE.201811714 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : ARIA REMARK 3 AUTHORS : LINGE, O'DONOGHUE AND NILGES REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6QEB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 15-JAN-19. REMARK 100 THE DEPOSITION ID IS D_1292100036. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 288 REMARK 210 PH : 7.5 REMARK 210 IONIC STRENGTH : 50 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 1 MM [U-99% 13C; U-99% 15N] REMARK 210 HCAII, 95% H2O/5% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D HCCH-TOCSY; 3D 1H-15N RFDR; REMARK 210 3D 1H-13C RFDR REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE III REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : ARIA, CCPNMR ANALYSIS REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 20 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : LOWEST ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 217 REMARK 217 SOLID STATE NMR STUDY REMARK 217 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLID REMARK 217 STATE NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 217 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 217 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 330 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17240 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -39.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 PRO A 21 33.68 -76.40 REMARK 500 1 GLN A 28 94.29 -62.66 REMARK 500 1 PRO A 42 29.29 -78.48 REMARK 500 1 TYR A 51 37.46 -173.95 REMARK 500 1 HIS A 64 -49.03 -175.03 REMARK 500 1 LYS A 76 -82.71 -64.29 REMARK 500 1 ASP A 101 38.12 -87.21 REMARK 500 1 GLU A 106 -75.72 -72.74 REMARK 500 1 PRO A 154 36.31 -79.81 REMARK 500 1 ILE A 166 51.25 -103.88 REMARK 500 1 ASP A 179 78.38 -117.47 REMARK 500 1 SER A 187 101.06 59.09 REMARK 500 1 TYR A 193 75.80 -162.64 REMARK 500 1 PRO A 200 154.17 -40.63 REMARK 500 1 PRO A 201 101.47 -57.73 REMARK 500 1 LEU A 202 -56.03 -131.94 REMARK 500 1 CYS A 205 35.69 -87.91 REMARK 500 1 ASN A 231 72.63 177.54 REMARK 500 1 GLU A 237 99.80 -52.80 REMARK 500 1 ASP A 242 38.66 -174.78 REMARK 500 1 ALA A 247 48.07 -173.19 REMARK 500 1 LYS A 251 -52.58 -161.75 REMARK 500 1 ASN A 252 90.86 57.69 REMARK 500 2 SER A 2 -66.79 -126.18 REMARK 500 2 HIS A 3 86.77 57.85 REMARK 500 2 TYR A 7 -61.46 -105.37 REMARK 500 2 HIS A 15 39.12 -165.45 REMARK 500 2 ASP A 19 -64.51 -152.57 REMARK 500 2 PRO A 21 39.44 -80.88 REMARK 500 2 GLU A 26 91.40 57.41 REMARK 500 2 GLN A 28 71.14 61.85 REMARK 500 2 PRO A 42 90.69 -58.97 REMARK 500 2 LEU A 47 -58.29 -134.94 REMARK 500 2 VAL A 49 113.96 -161.88 REMARK 500 2 TYR A 51 22.49 -150.81 REMARK 500 2 HIS A 64 -52.17 -168.29 REMARK 500 2 GLN A 74 -68.82 -141.92 REMARK 500 2 LYS A 76 -70.67 -158.14 REMARK 500 2 GLU A 106 -76.28 -83.11 REMARK 500 2 LYS A 111 10.81 59.74 REMARK 500 2 ALA A 152 103.28 -57.65 REMARK 500 2 ILE A 166 51.14 -110.19 REMARK 500 2 ALA A 173 118.65 -167.52 REMARK 500 2 SER A 187 90.23 55.09 REMARK 500 2 LEU A 188 -79.99 -144.09 REMARK 500 2 TYR A 193 73.56 -159.40 REMARK 500 2 LEU A 197 176.57 -59.67 REMARK 500 2 PRO A 200 155.46 -39.23 REMARK 500 2 PRO A 201 104.59 -34.24 REMARK 500 2 LEU A 202 -41.94 -132.46 REMARK 500 REMARK 500 THIS ENTRY HAS 489 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 301 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 94 NE2 REMARK 620 2 HIS A 96 NE2 109.1 REMARK 620 3 HIS A 119 ND1 108.6 109.0 REMARK 620 4 AZM A 302 N1 109.9 110.1 110.0 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ZN A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue AZM A 302 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 34347 RELATED DB: BMRB REMARK 900 ASSESSMENT OF A LARGE ENZYME-DRUG COMPLEX BY PROTON-DETECTED SOLID- REMARK 900 STATE NMR WITHOUT DEUTERATION DBREF 6QEB A 1 260 UNP P00918 CAH2_HUMAN 1 260 SEQRES 1 A 260 MET SER HIS HIS TRP GLY TYR GLY LYS HIS ASN GLY PRO SEQRES 2 A 260 GLU HIS TRP HIS LYS ASP PHE PRO ILE ALA LYS GLY GLU SEQRES 3 A 260 ARG GLN SER PRO VAL ASP ILE ASP THR HIS THR ALA LYS SEQRES 4 A 260 TYR ASP PRO SER LEU LYS PRO LEU SER VAL SER TYR ASP SEQRES 5 A 260 GLN ALA THR SER LEU ARG ILE LEU ASN ASN GLY HIS ALA SEQRES 6 A 260 PHE ASN VAL GLU PHE ASP ASP SER GLN ASP LYS ALA VAL SEQRES 7 A 260 LEU LYS GLY GLY PRO LEU ASP GLY THR TYR ARG LEU ILE SEQRES 8 A 260 GLN PHE HIS PHE HIS TRP GLY SER LEU ASP GLY GLN GLY SEQRES 9 A 260 SER GLU HIS THR VAL ASP LYS LYS LYS TYR ALA ALA GLU SEQRES 10 A 260 LEU HIS LEU VAL HIS TRP ASN THR LYS TYR GLY ASP PHE SEQRES 11 A 260 GLY LYS ALA VAL GLN GLN PRO ASP GLY LEU ALA VAL LEU SEQRES 12 A 260 GLY ILE PHE LEU LYS VAL GLY SER ALA LYS PRO GLY LEU SEQRES 13 A 260 GLN LYS VAL VAL ASP VAL LEU ASP SER ILE LYS THR LYS SEQRES 14 A 260 GLY LYS SER ALA ASP PHE THR ASN PHE ASP PRO ARG GLY SEQRES 15 A 260 LEU LEU PRO GLU SER LEU ASP TYR TRP THR TYR PRO GLY SEQRES 16 A 260 SER LEU THR THR PRO PRO LEU LEU GLU CYS VAL THR TRP SEQRES 17 A 260 ILE VAL LEU LYS GLU PRO ILE SER VAL SER SER GLU GLN SEQRES 18 A 260 VAL LEU LYS PHE ARG LYS LEU ASN PHE ASN GLY GLU GLY SEQRES 19 A 260 GLU PRO GLU GLU LEU MET VAL ASP ASN TRP ARG PRO ALA SEQRES 20 A 260 GLN PRO LEU LYS ASN ARG GLN ILE LYS ALA SER PHE LYS HET ZN A 301 1 HET AZM A 302 13 HETNAM ZN ZINC ION HETNAM AZM 5-ACETAMIDO-1,3,4-THIADIAZOLE-2-SULFONAMIDE FORMUL 2 ZN ZN 2+ FORMUL 3 AZM C4 H6 N4 O3 S2 HELIX 1 AA1 HIS A 15 PHE A 20 1 6 HELIX 2 AA2 LYS A 126 GLY A 128 5 3 HELIX 3 AA3 ASP A 129 VAL A 134 1 6 HELIX 4 AA4 LEU A 156 ASP A 164 1 9 HELIX 5 AA5 SER A 165 LYS A 167 5 3 HELIX 6 AA6 SER A 218 LYS A 224 1 7 HELIX 7 AA7 PHE A 225 LEU A 228 5 4 SHEET 1 AA1 2 LYS A 39 TYR A 40 0 SHEET 2 AA1 2 LYS A 256 ALA A 257 1 O ALA A 257 N LYS A 39 SHEET 1 AA2 5 VAL A 78 LEU A 79 0 SHEET 2 AA2 5 TYR A 88 PHE A 95 -1 O TYR A 88 N LEU A 79 SHEET 3 AA2 5 PHE A 66 PHE A 70 -1 N VAL A 68 O PHE A 93 SHEET 4 AA2 5 SER A 56 ASN A 61 -1 N ARG A 58 O GLU A 69 SHEET 5 AA2 5 SER A 172 ASP A 174 -1 O ALA A 173 N ILE A 59 SHEET 1 AA3 6 VAL A 78 LEU A 79 0 SHEET 2 AA3 6 TYR A 88 PHE A 95 -1 O TYR A 88 N LEU A 79 SHEET 3 AA3 6 LEU A 118 ASN A 124 -1 O HIS A 119 N HIS A 94 SHEET 4 AA3 6 VAL A 142 GLY A 144 -1 O LEU A 143 N LEU A 120 SHEET 5 AA3 6 VAL A 206 VAL A 210 1 O ILE A 209 N VAL A 142 SHEET 6 AA3 6 THR A 192 GLY A 195 -1 N TYR A 193 O TRP A 208 SHEET 1 AA4 2 LEU A 147 VAL A 149 0 SHEET 2 AA4 2 ILE A 215 VAL A 217 1 O VAL A 217 N LYS A 148 LINK NE2 HIS A 94 ZN ZN A 301 1555 1555 2.00 LINK NE2 HIS A 96 ZN ZN A 301 1555 1555 2.00 LINK ND1 HIS A 119 ZN ZN A 301 1555 1555 2.00 LINK ZN ZN A 301 N1 AZM A 302 1555 1555 2.00 SITE 1 AC1 4 HIS A 94 HIS A 96 HIS A 119 AZM A 302 SITE 1 AC2 5 HIS A 94 HIS A 96 HIS A 119 ASN A 243 SITE 2 AC2 5 ZN A 301 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1